Search For "biological e"
Updated : 3 weeks, 1 day ago IST
Houston [US], December 31 (ANI): Corbevax, a 'recombinant protein sub-unit' vaccine developed by Texas-based vaccine developers, was recently granted emergency approval by the Indian government and will be manufactured by the Hyderabad-based company Biological E, one of the world's largest v
Updated : 3 weeks, 3 days ago IST
New Delhi [India], December 29 (ANI): The Drug Controller General of India (DCGI) has given approval to the Hyderbad-based pharmaceutical company Biological E to conduct phase 3 clinical trials of its COVID-19 vaccine Corbevax as a booster dose, said sources.
Updated : 3 weeks, 4 days ago IST
New Delhi [India], December 28 (ANI): After reviewing all applications and data, the Subject Expert Committee (SEC), a body under India's drug regulator, has recommended granting the Emergency Use Authorization (EUA) to Serum Institute of India's COVID-19 vaccine Covovax and Corbevax vacc
Updated : 2 months, 4 weeks ago IST
Hyderabad (Telangana) [India], October 26 (ANI): To provide further momentum to the ongoing nationwide vaccination drive, the COVID-19 vaccine Corbevax vaccine will be rolled out by end of November, Biological E Limited said on Monday.
Hyderabad (Telangana) [India], October 25 (ANI): In a move towards fulfilling the commitment set by the "Quad" leaders, the U.S. International Development Finance Corporation and Biological E. Limited unveiled the expansion of Biological E.'s vaccine manufacturing facility in Hyderabad on Mo
Updated : 3 months, 1 week ago IST
New Delhi [India], October 16 (ANI): India will have a vaccine capacity of 28 crore doses this month, which includes 22 crore Serum Institute of India's Covishield and 6 crore doses of Bharat Biotech Biotech's Covaxin and production of 60 lakh Zydus Cadila's ZyCoV-D doses are also ready,
Washington [US], October 16 (ANI): US International Development Finance Corporation (DFC) Chief Operating Officer (COO) David Marchick will be visiting India from October 24-26 with an aim to advance DFC investments helping boost global health and expand COVID-19 vaccine production capaci
New Delhi [India], October 14 (ANI): Biological E will submit final data on COVID-19 vaccine Corbevax till November end, informed Government sources on Thursday.
Updated : 3 months, 4 weeks ago IST
Washington [US], September 25 (ANI): Leaders of the Quadrilateral Security Dialogue (Quad) on Friday appreciated India's announcement to resume exports of Covid-19 vaccines in October.
Updated : 4 months, 1 week ago IST
New Delhi [India], September 16 (ANI): Secretary, Department of Biotechnology, Government of India Dr Renu Swarup said that Drugs Controller General of India has given permission to Christian Medical College, Vellore to start a trial on the mixing of COVID-19 vaccines while adding that th
Updated : 4 months, 3 weeks ago IST
New Delhi [India], September 2 (ANI): Hyderabad-based pharmaceutical company, Biological E, is expected to launch its vaccine against coronavirus in October this year, according to Dr V K Paul, Member (Health), NITI Aayog.
New Delhi [India], September 2 (ANI): The Drug Controller General of India (DCGI) on Wednesday granted permission to Hyderabad-based Biological E Limited to conduct Phase 2 & 3 clinical trials for its anti-COVID shots called Corbevax on children between 5 and 18 years of age with certain